These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31848320)

  • 1. Genetic diversity affects the nanoscale membrane organization and signaling of natural killer cell receptors.
    Kennedy PR; Barthen C; Williamson DJ; Pitkeathly WTE; Hazime KS; Cumming J; Stacey KB; Hilton HG; Carrington M; Parham P; Davis DM
    Sci Signal; 2019 Dec; 12(612):. PubMed ID: 31848320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk.
    Peterson ME; Long EO
    Immunity; 2008 Oct; 29(4):578-88. PubMed ID: 18835194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Size of Activating and Inhibitory Killer Ig-like Receptor Nanoclusters Is Controlled by the Transmembrane Sequence and Affects Signaling.
    Oszmiana A; Williamson DJ; Cordoba SP; Morgan DJ; Kennedy PR; Stacey K; Davis DM
    Cell Rep; 2016 May; 15(9):1957-72. PubMed ID: 27210755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).
    Long EO; Barber DF; Burshtyn DN; Faure M; Peterson M; Rajagopalan S; Renard V; Sandusky M; Stebbins CC; Wagtmann N; Watzl C
    Immunol Rev; 2001 Jun; 181():223-33. PubMed ID: 11513144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant.
    Lin Chua H; Brahmi Z
    Cell Immunol; 2002 Sep; 219(1):57-70. PubMed ID: 12473268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.
    Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK
    Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The killer-cell immunoglobulin-like receptors of macaques.
    Bimber BN; Evans DT
    Immunol Rev; 2015 Sep; 267(1):246-58. PubMed ID: 26284482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs.
    Béziat V; Liu LL; Malmberg JA; Ivarsson MA; Sohlberg E; Björklund AT; Retière C; Sverremark-Ekström E; Traherne J; Ljungman P; Schaffer M; Price DA; Trowsdale J; Michaëlsson J; Ljunggren HG; Malmberg KJ
    Blood; 2013 Apr; 121(14):2678-88. PubMed ID: 23325834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2004 Jun; 172(12):7385-92. PubMed ID: 15187115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tyrosine phosphatase SHP-1 promotes T cell adhesion by activating the adaptor protein CrkII in the immunological synapse.
    Azoulay-Alfaguter I; Strazza M; Peled M; Novak HK; Muller J; Dustin ML; Mor A
    Sci Signal; 2017 Aug; 10(491):. PubMed ID: 28790195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand binding to inhibitory killer cell Ig-like receptors induce colocalization with Src homology domain 2-containing protein tyrosine phosphatase 1 and interruption of ongoing activation signals.
    Vyas YM; Maniar H; Lyddane CE; Sadelain M; Dupont B
    J Immunol; 2004 Aug; 173(3):1571-8. PubMed ID: 15265884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killer cell immunoglobulin-like receptors influence the innate and adaptive immune responses.
    Rajalingam R
    Iran J Immunol; 2007 Jun; 4(2):61-78. PubMed ID: 17652846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49.
    McVicar DW; Burshtyn DN
    Sci STKE; 2001 Mar; 2001(75):re1. PubMed ID: 11752646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.
    Nowak I; Malinowski A; Tchorzewski H; Barcz E; Wilczynski JR; Grybos M; Kurpisz M; Luszczek W; Banasik M; Reszczynska-Slezak D; Majorczyk E; Wisniewski A; Senitzer D; Yao Sun J; Kusnierczyk P
    J Appl Genet; 2009; 50(4):391-8. PubMed ID: 19875891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic polymorphisms of
    Shindo T; Ureshino H; Kojima H; Tanaka H; Kimura S
    Immunol Med; 2021 Jun; 44(2):61-68. PubMed ID: 32715973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
    Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
    J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cells.
    Older Aguilar AM; Guethlein LA; Adams EJ; Abi-Rached L; Moesta AK; Parham P
    J Immunol; 2010 Oct; 185(7):4238-51. PubMed ID: 20805421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic variability in SHP-1 abundance determines natural killer cell responsiveness.
    Wu Z; Park S; Lau CM; Zhong Y; Sheppard S; Sun JC; Das J; Altan-Bonnet G; Hsu KC
    Sci Signal; 2021 Nov; 14(708):eabe5380. PubMed ID: 34752140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.
    Rettman P; Blunt MD; Fulton RJ; Vallejo AF; Bastidas-Legarda LY; España-Serrano L; Polak ME; Al-Shamkhani A; Retiere C; Khakoo SI
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.